Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Botox Adds Therapeutic Indication For Idiopathic Overactive Bladder

Jan 22 2013

Related Content

Astellas Expands Its Presence In Urology With <em>Myrbetriq</em> Approval

Jul 02 2012

NICE Clears Botox For Chronic Migraine, With Therapy “Stopping Rules”

Jun 27 2012

Related Companies

Allergan plc

Astellas Pharma, Inc.

Additional Topics

Launches BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window